l-carnitine tmao koeth 2013 nature medicine JCI Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis:
Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy Frontiers Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect
Pay in 4 interest-free payments of $5.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27



